The print · 8-K and call2026-11-04 · After close
Revenue$656M
est. —
EPS$2.65
est. —
Guidance · FY revenue-$3.00–$0.50no comparable consensus
Bio-Rad Laboratories, Inc. · Medical Devices
BIO Bio-Rad Laboratories, Inc. · Earnings
Reports 2026-11-04 After close · WedReaction day 11-05reported · reaction in progress
Get BIO's results by email the night it reports
EPS and revenue vs. estimates, plus the first-day move. Free — unsubscribe in one click.
Report card
Done· 8-K + call· 11-04 After closeBreakdown
Key figures, the focus-point check, management quotes, the sector read and the grade are in the full view. Start 30-day free trial →
Reaction
Now· open / day / 5-day· 11-05 → day 5Reactionreaction not yet settled
After-hours move—no read yet
Open / day close— / —
5 days later—day 5 pending
Going in
Done· T-7 → T-1 freezeBefore the print · expectationsfrozen at T-1
No past prints on file yet.
Pricing going in · as of the 11-04 close
+3.2%Move over the last 20 sessionsLast 5 sessions −1.4%
−9.1 ptsvs sector (XLV)XLV over the same window +12.4%
—Forward P/EConsensus: not available
What the record doesn't tell you
Which way does BIO go on 11‑04?
- Model lean for 11-04, and the evidence behind it
- Move band, P10 – P90
- Last 8 prints, quarter by quarter
- Peers that already reported, and how they traded
Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →
Bio-Rad Laboratories earnings review: what the record says
Bio-Rad Laboratories (BIO) reported earnings on Nov 4, 2026, after the close. The company posted EPS of $2.65 and revenue of $656M.
NextPick tracks BIO in its Life Sciences Tools basket alongside TMO, DHR, A, WAT, MTD, MEDP, RVTY and CRL, whose prints read through to this one.
Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.